![Gerhard Wolff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karriereverlauf von Gerhard Wolff
Ehemalige bekannte Positionen von Gerhard Wolff
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
National Institute of Health Policy | Corporate Officer/Principal | - | - |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | Corporate Officer/Principal | - | - |
Revotar Biopharmaceuticals AG
![]() Revotar Biopharmaceuticals AG Pharmaceuticals: MajorHealth Technology Revotar Biopharmaceuticals AG specializes in the research and development of anti-inflammatory drugs. The firm develops drugs for the therapy and treatment of inflammatory disorders such as psoriasis, asthma and acute lung injuries, and chronic obstructive pulmonary diseases. Its focus areas include product licensing, drug discovery, and clinical development. The firm also engages in partnerships and projects with biotechnology research institutions and pharmaceutical enterprises. The company was founded in August 2000 and is headquartered in Hennigsdorf, Germany. | Corporate Officer/Principal | 20.12.2005 | - |
Ausbildung von Gerhard Wolff
Universität Leipzig | Doctorate Degree |
Statistik
International
Deutschland | 3 |
Vereinigte Staaten | 3 |
Operativ
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Revotar Biopharmaceuticals AG
![]() Revotar Biopharmaceuticals AG Pharmaceuticals: MajorHealth Technology Revotar Biopharmaceuticals AG specializes in the research and development of anti-inflammatory drugs. The firm develops drugs for the therapy and treatment of inflammatory disorders such as psoriasis, asthma and acute lung injuries, and chronic obstructive pulmonary diseases. Its focus areas include product licensing, drug discovery, and clinical development. The firm also engages in partnerships and projects with biotechnology research institutions and pharmaceutical enterprises. The company was founded in August 2000 and is headquartered in Hennigsdorf, Germany. | Health Technology |
National Institute of Health Policy |
- Börse
- Insiders
- Gerhard Wolff
- Erfahrung